The nurse is caring for a client with hypertension, gastroesophageal reflux, and osteoarthritis. While performing a bedside assessment the nurse observes the client is alert and oriented, but is exhibiting signs of jaundice. The nurse should notify the healthcare provider about which scheduled medication?

A) While measuring the client’s vital signs is a routine nursing intervention, the reported symptoms of confusion and blurred vision after receiving glipizide suggest the possibility of hypoglycemia. Vital signs may not provide immediate information about the client’s glucose levels or help confirm hypoglycemia. However, if the client’s symptoms persist or worsen, assessing vital signs becomes important to monitor for signs of shock or other complications.

B) Obtaining a fingerstick blood glucose is the priority action in this situation. Glipizide is an oral antidiabetic medication that stimulates insulin release from the pancreas, leading to lower blood glucose levels. Symptoms such as confusion and blurred vision are indicative of hypoglycemia, a potential adverse effect of glipizide. Checking the client’s blood glucose level will confirm hypoglycemia and guide further interventions.

C) While performing a neurological exam may be warranted if the client’s symptoms persist or if there are concerns about other neurological issues, confirming hypoglycemia with a fingerstick blood glucose test should be the immediate priority.

D) Administering glucagon intramuscularly (IM) is indicated for severe hypoglycemia when the client is unconscious or unable to swallow. However, in this scenario, the client is conscious and able to report symptoms. Before administering glucagon, it is essential to confirm hypoglycemia with a blood glucose measurement to avoid unnecessary interventions.

Therefore, the nurse should promptly obtain a fingerstick blood glucose to confirm hypoglycemia and initiate appropriate treatment for the client’s symptoms.

A) Taking the medication one hour after meals and other medications may help prevent interference with the absorption of nutrients or other medications. However, it is not a specific instruction related to the administration of bulk-forming laxatives.

B) Remaining upright for thirty minutes following drug administration is a common instruction for medications that may cause esophageal irritation or reflux. However, it is not typically necessary for bulk-forming laxatives, which work primarily in the colon rather than the esophagus or stomach.

C) Following medication administration with an additional glass of water is the correct instruction for self-administration of bulk-forming laxatives. These laxatives absorb water in the intestines, which helps to soften the stool and promote bowel movements. Adequate hydration is essential to prevent the bulk-forming laxative from causing intestinal obstruction.

D) Avoiding the intake of dairy products while using the medication is not a specific instruction related to the administration of bulk-forming laxatives. Bulk-forming laxatives are generally well-tolerated and do not interact with dairy products. However, increasing fluid intake, particularly water, is essential to prevent constipation and ensure the effectiveness of the medication.